Eva Åström

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: NEUROLOGY. 2024;102(2):e207948
Bisphosphonates in Glucocorticoid-Treated Patients With Duchenne Muscular Dystrophy
Landfeldt E; Phung K; Zaman F; Astrom E; Abner S; Lochmuller H; Sejersen T; Ward LM
Article: BMC MUSCULOSKELETAL DISORDERS. 2022;23(1):876
Exploring pain interference and self-perceived health status in children with osteogenesis imperfecta-a cross-sectional study
Provenzano AH; Astrom E; Lowing K
Article: CLINICAL OBSTETRICS AND GYNECOLOGY. 2021;64(4):898-903
Mesenchymal Stem Cell Therapy for Osteogenesis Imperfecta
Gotherstrom C; David AL; Walther-Jallow L; Astrom E; Westgren M
Article: CALCIFIED TISSUE INTERNATIONAL. 2021;109(2):121-131
Abnormalities in Tooth Formation after Early Bisphosphonate Treatment in Children with Osteogenesis Imperfecta
Malmgren B; Thesleff I; Dahllof G; Astrom E; Tsilingaridis G
Article: CALCIFIED TISSUE INTERNATIONAL. 2020;107(2):143-150
Bisphosphonate Therapy and Tooth Development in Children and Adolescents with Osteogenesis Imperfecta
Malmgren B; Tsilingaridis G; Monsef-Johansson N; Al Qahtani ZH; Dahllof G; Astrom E
Article: ORPHANET JOURNAL OF RARE DISEASES. 2020;15(1):80
Mutations in COL1A1/A2 and CREB3L1 are associated with oligodontia in osteogenesis imperfecta
Andersson K; Malmgren B; Astrom E; Nordgren A; Taylan F; Dahllof G
Article: BONE. 2018;114:268-277
Homozygosity for CREB3L1 premature stop codon in first case of recessive osteogenesis imperfecta associated with OASIS-deficiency to survive infancy
Lindahl K; Astrom E; Dragomir A; Symoens S; Coucke P; Larsson S; Paschalis E; Roschger P; Gamsjaeger S; Klaushofer K; Fratzl-Zelman N; Kindmark A
Article: ORPHANET JOURNAL OF RARE DISEASES. 2018;13(1):145
Dentinogenesis imperfecta type II in Swedish children and adolescents
Andersson K; Malmgren B; Astrom E; Dahllof G
Article: JOURNAL OF BONE AND MINERAL RESEARCH. 2018;33(4):753-760
Expanding the Clinical Spectrum of Phenotypes Caused by Pathogenic Variants in PLOD2
Leal GF; Nishimura G; Voss U; Bertola DR; Astrom E; Svensson J; Yamamoto GL; Hammarsjo A; Horemuzova E; Papadiogannakis N; Iwarsson E; Grigelioniene G; Tham E
Article: ORAL DISEASES. 2017;23(1):42-49
Tooth agenesis in osteogenesis imperfecta related to mutations in the collagen type I genes
Malmgren B; Andersson K; Lindahl K; Kindmark A; Grigelioniene G; Zachariadis V; Dahllof G; Astrom E
Article: PLOS ONE. 2017;12(5):e0176466
Mutations in COL1A1 and COL1A2 and dental aberrations in children and adolescents with osteogenesis imperfecta - A retrospective cohort study
Andersson K; Dahllof G; Lindahl K; Kindmark A; Grigelioniene G; Astrom E; Malmgren B
Article: BONE. 2016;87:11-18
Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate
Lindahl K; Kindmark A; Rubin C-J; Malmgren B; Grigelioniene G; Soderhall S; Ljunggren O; Astrom E
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2015;23(8):1042-1050
Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta
Lindahl K; Astrom E; Rubin C-J; Grigelioniene G; Malmgren B; Ljunggren O; Kindmark A
Article: DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY. 2015;57(5):484-490
A prospective cohort study investigating gross motor function, pain, and health-related quality of life 17 years after selective dorsal rhizotomy in cerebral palsy
Tedroff K; Lowing K; Astrom E
Article: AMERICAN JOURNAL OF MEDICAL GENETICS, PART A. 2014;164(7):1635-1641
Autosomal dominant brachyolmia in a large Swedish family: Phenotypic spectrum and natural course
Grigelioniene G; Geiberger S; Horemuzova E; Mostrom E; Jantti N; Neumeyer L; Astrom E; Nordenskjold M; Nordgren A; Makitie O
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2014;3(2):255-264
Pre- and Postnatal Transplantation of Fetal Mesenchymal Stem Cells in Osteogenesis Imperfecta: A Two-Center Experience
Gotherstrom C; Westgren M; Shaw SWS; Astrom E; Biswas A; Byers PH; Mattar CNZ; Graham GE; Taslimi J; Ewald U; Fisk NM; Yeoh AEJ; Lin J-L; Cheng P-J; Choolani M; Le Blanc K; Chan JKY
Article: INTERNATIONAL JOURNAL OF MEDICAL SCIENCES. 2013;10(10):1333-1343
Allele Dependent Silencing of Collagen Type I Using Small Interfering RNAs Targeting 3'UTR Indels - a Novel Therapeutic Approach in Osteogenesis Imperfecta
Lindahl K; Kindmark A; Laxman N; Astrom E; Rubin C-J; Ljunggren O
Article: DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY. 2011;53(8):724-729
Does loss of spasticity matter? A 10-year follow-up after selective dorsal rhizotomy in cerebral palsy
Tedroff K; Lowing K; Jacobson DNO; Astrom E
Article: HORMONE RESEARCH IN PAEDIATRICS. 2011;75(5):354-361
Intravenous Pamidronate Treatment Improves Growth in Prepubertal Osteogenesis Imperfecta Patients
Heino TJ; Astrom E; Laurencikas E; Savendahl L; Soderhall S
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2010;99(12):1834-1840
Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta
Astrom E; Magnusson P; Eksborg S; Soderhall S
Article: JOURNAL OF ORAL PATHOLOGY & MEDICINE. 2008;37(4):196-200
No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates
Malmgren B; Atrom E; Soderhall S
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2007;96(8):1180-1183
Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta
Lowing K; Astrom E; Oscarsson KA; Soderhall S; Eliasson A-C
Article: ARCHIVES OF DISEASE IN CHILDHOOD. 2007;92(4):332-338
Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta
Astrom E; Jorulf H; Soderhall S
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2007;96(3):446-449
Medical problems in adolescents with myelomeningocele (MMC):: an inventory of the Swedish MMC population born during 1986-1989
Olsson I; Dahl M; Mattsson S; Wendelius M; Astrom E; Westbom L
Article: TRANSPLANTATION. 2005;79(11):1607-1614
Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta
Le Blanc K; Götherström C; Ringdén O; Hassan M; McMahon R; Horwitz E; Anneren G; Axelsson O; Nunn J; Ewald U; Nordén-Lindeberg S; Jansson M; Dalton A; Åström E; Westgren M
Article: ARCHIVES OF DISEASE IN CHILDHOOD. 2002;86(5):356-364
Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta.
Aström E; Söderhäll S
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 1998;87(1):64-68
Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta
Åström E; Söderhäll S
Visa fler

Alla övriga publikationer

Letter: AMERICAN JOURNAL OF MEDICAL GENETICS, PART A. 2017;173(12):3132-3135
Novel mutations in the LRP5 gene in patients with Osteoporosis-pseudoglioma syndrome
Pekkinen M; Grigelioniene G; Akin L; Shah K; Karaer K; Kurtoglu S; Ekbote A; Aycan Z; Sagsak E; Danda S; Astrom E; Makitie O
Corrigendum: EUROPEAN JOURNAL OF HUMAN GENETICS. 2015;23(8):1112
Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta.
Lindahl K; Åström E; Rubin C-J; Grigelioniene G; Malmgren B; Ljunggren Ö; Kindmark A
Meeting abstract: BONE. 2011;48:S94
Allele dependent silencing of collagen type I using small interfering RNAs targeting 3′UTR indels-A novel therapeutic approach in osteogenesis imperfecta
Lindahl K; Kindmark A; Astrom E; Rubin C-J; Ljunggren O
Thesis / dissertation: 2007
Bisphosphonate treatment of children and adolescents with osteogenesis imperfecta : effects on clinical symptoms and bone turnover
Åström, Eva

Anställningar

Anknuten till Forskning, Kvinnors och barns hälsa, Karolinska Institutet, 2024-2027

Examina och utbildning

MEDICINE DOKTORSEXAMEN, Institutionen för kvinnors och barns hälsa, Karolinska Institutet, 2007

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI